Neogen Corporation (OGEN)

Frankfurt


	Symbol		Exchange		Currency
	NEOG		NASDAQ		USD	Real-time
	OGEN		Frankfurt		EUR	Delayed

Currency in EUR

Disclaimer

12.50

-1.20(-8.76%)

Closed12/10

Fair Value

Day's Range

12.50

12.50

52 wk Range

10.70

18.60

OGEN Income Statement

Featured here, the Income Statement (earnings report) for Neogen Corporation, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/05

2016

31/05

2017

31/05

2018

31/05

2019

31/05

2020

31/05

2021

31/05

2022

31/05

2023

31/05

2024

31/05

Total Revenues

418.17

468.46

527.16

822.45

924.22

Total Revenues Growth

+0.96%

+12.03%

+12.53%

+56.01%

+12.37%

Cost Of Revenues

221.89

253.4

284.15

413.25

460.32

Gross Profit

196.28

215.06

243.01

409.2

463.9

Gross Profit Growth

+2.27%

+9.57%

+13%

+68.39%

+13.37%

Gross Profit Margin %

46.94%

45.91%

46.1%

49.75%

50.19%

Other Operating Expenses, Total

128.76

137.8

158.81

306.52

389.16

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+3.98%	+7.03%	+15.25%	+93.01%	+26.96%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	14.75	16.25	17.05	26.04	22.48
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	114.01	121.56	141.77	280.48	366.68
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

67.52

77.25

84.2

102.68

74.74

Operating Income Growth

-0.84%

+14.41%

+8.99%

+21.95%

-27.21%

EBIT Margin %

16.15%

16.49%

15.97%

12.48%

8.09%

Net Interest Expenses

5.99

1.61

1.27

-52.8

-67.03

Net Interest Expenses Growth

+27.95%

-73.06%

-21.5%

-4,266.93%

-26.97%

Interest Expense, Total

-

-0.08

-0.07

-55.96

-73.39

Interest And Investment Income

5.99

1.69

1.34

3.17

6.36

Other Non Operating Expenses, Total

-1.21

-0.52

0.32

-7.06

-5.64

EBT, Excl. Unusual Items

72.31

78.35

85.79

42.82

2.07

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-

-

-

0.3

-0.3

EBT, Incl. Unusual Items

72.31

75.27

60.21

-22.04

-14.31

EBT, Incl. Unusual Items Growth

-0.9%

+4.1%

-20.01%

-136.61%

+35.1%

EBT, Incl. Unusual Items Margin

17.29%

16.07%

11.42%

-2.68%

-1.55%

Income Tax Expense

12.83

14.39

11.9

0.83

-4.88

Net Income to Company

59.48

60.88

48.31

-22.87

-9.42

Minority Interest

-

-

-

-

-

Net Income

59.48

60.88

48.31

-22.87

-9.42

Net Income Growth

-1.16%

+2.37%

-20.65%

-147.34%

+58.81%

Net Income Margin %

14.22%

13%

9.16%

-2.78%

-1.02%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

59.48

60.88

48.31

-22.87

-9.42

Basic EPS - Continuing Operations

0.57

0.57

0.45

-0.12

-0.04

Basic EPS - Continuing Operations Growth

-2.41%

+1.02%

-21.53%

-126.99%

+64.06%

Diluted EPS - Continuing Operations

0.56

0.57

0.45

-0.12

-0.04

Diluted EPS - Continuing Operations Growth

-1.75%

+1.79%

-21.3%

-126.99%

+64.06%

Basic Weighted Average Shares Outstanding

105.1

106.5

107.68

188.88

216.48

Diluted Weighted Average Shares Outstanding

105.72

107.12

108.02

188.88

216.48

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

85.92

98.3

107.89

191.06

191.46

EBITDA Growth

+0.23%

+14.4%

+9.76%

+77.08%

+0.21%

EBITDA Margin %

20.55%

20.98%

20.47%

23.23%

20.72%

EBIT

67.52

77.25

84.2

102.68

74.74

* In Millions of USD (except for per share items)